hexamethylmelamine (altretamine) in small cell lung cancer (SCLG)COMIS, R. L.Cancer treatment reviews. 1991, Vol 18, pp 85-90, issn 0305-7372, 6 p., SUPAArticle

The role of surgery in small cell lung cancer: a reappraisalCOMIS, R. L.Clinics in oncology. 1985, Vol 4, Num 1, pp 141-151, issn 0261-9873Article

Extensive small cell lung cancerCOMIS, R. L.Lung cancer. 1993, Vol 9, pp S27-S39, issn 0169-5002, SUPConference Paper

Oral etoposide in oncology : an evolving roleCOMIS, R. L.Annals of oncology. 1992, Vol 3, pp 63-67, issn 0923-7534, SUP3Conference Paper

Carboplatin in the treatment of non-small cell lung cancer : a reviewCOMIS, R. L.Oncology. 1993, Vol 50, pp 37-41, issn 0030-2414, SUP2Conference Paper

Developments in therapy for extensive-disease small cell lung cancerCOMIS, R. L.Seminars in oncology. 1992, Vol 19, Num 6, pp 45-50, issn 0093-7754, SUP13Conference Paper

SYSTEMIC CHEMOTHERAPY FOR A PRIMARY GERM CELL TUMOR OF THE BRAIN: A PHARMACOKINETIC STUDYGINSBERG S; KIRSHNER J; REICH S et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 5-6; PP. 477-483; BIBL. 23 REF.Article

PHARMACOKINETICS OF VINBLASTINE-LOADED PLATELETS UTILIZED IN THE TREATMENT OF PLATELET-PHAGOCYTIZING TUMORSPANASCI LC; COMIS R; GINSBERG S et al.1980; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1980; VOL. 64; NO 12; PP. 1227-1233; BIBL. 9 REF.Article

SEVERE TOXICITY AND DEATH ASSOCIATED WITH ZINOSTATIN ADMINISTRATIONVOSIKA G; COOPER MR; VOGELZANG N et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 2; PP. 410-411; BIBL. 5 REF.Article

COMBINATION CHEMOTHERAPY AND RADIOTHERAPY IN SMALL-CELL CARCINOMA OF THE LUNG.KING GA; COMIS R; GINSBERG S et al.1977; RADIOLOGY; U.S.A.; DA. 1977; VOL. 125; NO 2; PP. 529-530; BIBL. 4 REF.Article

PSYCHOLOGICAL RESPONSE OF PATIENTS RECEIVING TWO DRUG REGIMENS FOR LUNG CARCINOMASILBERFARB PM; HOLLAND JCB; ANBAR D et al.1983; AM. J. PSYCHIATRY; ISSN 0002-953X; USA; DA. 1983; VOL. 140; NO 1; PP. 110-111; BIBL. 5 REF.Article

ROLE OF CHEMOTHERAPY IN SMALL CELL LUNG CANCER: A CONSENSUS REPORT OF THE INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER WORKSHOP = ROLE DE LA CHIMIOTHERAPIE DANS LE CANCER A PETITES CELLULES DU POUMON: RAPPORT SUR LES TRAVAUX DE L'"INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCERAISNER J; ALBERTO P; BITRAN J et al.1983; CANCER TREATMENT REPORTS; ISSN 0361-5960; USA; DA. 1983; VOL. 67; NO 1; PP. 37-43; ABS. ENG; BIBL. 57 REF.Conference Paper

PHASE I TRIAL OF CHLOROZOTOCIN: ATTEMPTED AMELIORATION OF MYELOTOXICITY BY GLUCOSE ADMINISTRATIONPANASCI L; COMIS R; GINSBERG S et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 7-8; PP. 647-650; BIBL. 12 REF.Article

The Cooperative Groups : Past and futureCOMIS, R. L.Cancer chemotherapy and pharmacology. 1998, Vol 42, pp S85-S87, issn 0344-5704, SUPConference Paper

Perioperative therapy of non-small cell lung cancer : a review of adjuvant and neoadjuvant approachesFRIEDLAND, D. M; COMIS, R. L.Seminars in oncology. 1995, Vol 22, Num 6, pp 571-581, issn 0093-7754Article

Small cell carcinoma of the lung : An updated overviewMARTIN, V. R; COMIS, R. L.Seminars in oncology nursing. 1996, Vol 12, Num 4, pp 295-303, issn 0749-2081Article

Phase I trial of 5-fluorouracil, leucovorin, and cisplatin in combinationO'DWYER, P. J; CORNFELD, M. J; PETER, R et al.Cancer chemotherapy and pharmacology. 1990, Vol 27, Num 2, pp 131-134, issn 0344-5704, 4 p.Article

Future directions in the treatment of non-small cell lung cancerCOMIS, R. L; FINLEY, R. S.Seminars in oncology. 1999, Vol 26, Num 6, pp 14-18, issn 0093-7754, SUP18Conference Paper

Bisantrene in non-small cell lung cancer: a phase II trial of the cancer and leukemia group BGREEN, M. R; VOSIKA, G; PROPERT, K. J et al.Cancer treatment reports. 1986, Vol 70, Num 4, pp 539-540, issn 0361-5960Article

Phase I study of sequentially administered recombinant tumor necrosis factor and recombinant interleukin-2KRIGEL, R. L; PADAVIC-SHALLER, K; TOOMEY, C et al.Journal of immunotherapy with emphasis on tumor immunology. 1995, Vol 17, Num 3, pp 161-170, issn 1067-5582Article

New chemotherapy agents in the treatment of advanced non-small cell lung cancer : an update including data from the Seventh World Conference on Lung CancerCOMIS, R. L; FRIEDLAND, D. M.Lung cancer. 1995, Vol 12, pp S63-S99, issn 0169-5002, SUP2Conference Paper

Divergent dose-related effects of γ-interferon therapy on in vitro antibody-dependent cellular and nonspecific cytotoxicity by human peripheral blood monocytesWEINER, L. M; STEPLEWSKI, Z; KOPROWSKI, H et al.Cancer research (Baltimore). 1988, Vol 48, Num 4, pp 1042-1046, issn 0008-5472Article

Noncorrelation of the expression of the c-myc oncogene in colorectal carcinoma with recurrence of disease or patient survivalERISMAN, M. D; LITWIN, S; KEIDAN, R. D et al.Cancer research (Baltimore). 1988, Vol 48, Num 5, pp 1350-1355, issn 0008-5472Article

Recruiting Minority cancer patients into cancer clinical trials : A pilot project involving the Eastern Cooperative Oncology Group and the National medical associationMCCASKILL-STEVENS, W; PINTO, H; MARCUS, A. C et al.Journal of clinical oncology. 1999, Vol 17, Num 3, pp 1029-1039, issn 0732-183XArticle

The role of oral etoposide in non-small cell lung cancerCOMIS, R. L; FRIEDLAND, D. M; GOOD, B. C et al.Drugs (Basel). 1999, Vol 58, pp 21-30, issn 0012-6667, SUP3Conference Paper